At close: December 13 at 4:00:02 PM EST
After hours: December 13 at 6:05:40 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
10,544.0000
10,136.0000
13,437.0000
11,357.0000
9,089.0000
Operating Income
-10,544.0000
-10,136.0000
-13,437.0000
-11,357.0000
-9,089.0000
Net Non Operating Interest Income Expense
226.0000
283.0000
54.0000
44.0000
-80.0000
Other Income Expense
--
-887.0000
215.0000
44.0000
--
Pretax Income
-11,205.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Net Income Common Stockholders
-11,205.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Diluted NI Available to Com Stockholders
-11,205.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Basic EPS
-0.79
-1.05
-1.81
-1.59
-1.29
Diluted EPS
-0.79
-1.05
-1.81
-1.59
-1.29
Basic Average Shares
14,307.1620
10,199.9840
7,260.3440
7,108.1330
7,117.7470
Diluted Average Shares
14,307.1620
10,199.9840
7,260.3440
7,108.1330
7,117.7470
Total Operating Income as Reported
-10,263.0000
-9,855.0000
-13,281.0000
-11,357.0000
-9,089.0000
Total Expenses
10,544.0000
10,136.0000
13,437.0000
11,357.0000
9,089.0000
Net Income from Continuing & Discontinued Operation
-11,205.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Normalized Income
-10,318.0000
-9,853.0000
-13,383.0000
-11,357.0000
-9,169.0000
Interest Income
--
283.0000
54.0000
--
--
Interest Expense
--
--
--
--
80.0000
Net Interest Income
226.0000
283.0000
54.0000
44.0000
-80.0000
EBIT
-10,544.0000
-10,136.0000
-13,437.0000
-11,357.0000
-9,089.0000
EBITDA
-10,444.0000
-10,030.0000
-13,335.0000
-11,281.0000
-9,021.0000
Reconciled Depreciation
100.0000
106.0000
102.0000
76.0000
68.0000
Net Income from Continuing Operation Net Minority Interest
-11,205.0000
-10,740.0000
-13,168.0000
-11,313.0000
-9,169.0000
Total Unusual Items Excluding Goodwill
-887.0000
-887.0000
215.0000
44.0000
--
Total Unusual Items
-887.0000
-887.0000
215.0000
44.0000
--
Normalized EBITDA
-9,557.0000
-9,143.0000
-13,550.0000
-11,325.0000
-9,021.0000
12/31/2020 - 3/25/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVGR Avinger, Inc.
0.6309
+2.37%
AKYA Akoya Biosciences, Inc.
2.2700
-6.58%
EKSO Ekso Bionics Holdings, Inc.
0.5667
-0.75%
POAI Predictive Oncology Inc.
0.7799
-1.65%
ANGO AngioDynamics, Inc.
9.00
-1.96%
FEMY Femasys Inc.
1.1900
0.00%
EMBC Embecta Corp.
19.51
-0.86%
STSS Sharps Technology, Inc.
2.0400
+2.51%
ZJYL Jin Medical International Ltd.
0.7780
+2.38%
MLSS Milestone Scientific Inc.
0.8100
-2.41%